Market Pathways’ Post

Let’s connect and create impactful solutions for a healthier future! EVA pharma RauCon Business Development See you in Dublin! 🌟 . . . . . . #EuroPLX #PharmaIndustry #BusinessDevelopment #Partnerships #Collaboration #Innovation #Healthcare #Biotech #Pharmaceuticals #LifeSciences #DrugDevelopment #HealthcareInnovation #ClinicalResearch #PharmaBusiness #HealthTech #GlobalHealth #MedicalResearch #PharmaPartnerships #BusinessGrowth #IndustryLeaders #HealthSolution

How does orphan drug regulation impact patient care under Germany's AMNOG framework? As innovation accelerates in rare diseases, understanding regulatory and pricing implications has never been more critical. Our latest report for the vfa dives deep into the challenges and opportunities facing pharmaceutical companies, healthcare systems, and patients. Explore insights into balancing market access, affordability, and innovation in this complex landscape. Read the full report here: skp.link/t32i Join the conversation: What do you see as the biggest challenge for orphan drugs under AMNOG? #BetterMarketAccess #OrphanDrugs #Pharma #MarketAccess #SimonKucher

Africa’s Healthcare Uprising: Medicine Manufacturers Kickstart a Revolution to Redefine the Continent’s Future AMMTEC 2024 unites Africa’s pharmaceutical industry to spark a healthcare transformation 2 December 2024 – The close of the first African Medicines Manufacturing Trade Exhibition and Conference (AMMTEC) ushers in a new era of energy and commitment, shaking up the status quo in the manufacturing of medicines for the continent’s health systems.... lire la suite https://lnkd.in/e43RPHj9 #AMMTEC #Event #Conference #TradeExhibition #pharmaceuticalindustry #Logistafrica

Tomorrow I'll be speaking at the Digital Health Nexus conference on the 'Intersection between the Healthcare Provider & Pharmaceutical Industry In Digital Health Innovation'. I'll be discussing the potential for partnerships between NHS providers, digital innovators, and the pharmaceutical sector, while addressing common challenges and offering advice for achieving effective collaboration. Looking forward to connecting with attendees and feel free to share your thoughts on the topic! Nexus Conference ABHI Open Medical #digitalhealth #healthtech #healthcareinnovation #pharma #digitaltransformation #nhs

Radio Romania from Romania also reported on the launch of the Public Pharma for Europe coalition. The publication highlighted that the group emphasizes the argument that the current profit-driven pharmaceutical model is characterised by several dysfunctions that significantly hinder the global realisation of the right to health. These dysfunctions result in a lack of innovation, the private appropriation of public resources, shortages of essential health technologies, exorbitant medication prices, evidence-biased clinical trials, and distortions in drug prescriptions. They also deepen tensions and inequities between the Global North and the Global South. 🔗Check out the news (in Romanian): https://lnkd.in/etn9nD63 #PPfE #PublicPharma #publicpharmaeurope

Spotlight on Pharma Innovators at Mobile in Clinical Trials 2024 -- As we gear up for this year's conference, we want to highlight the 15 confirmed pharmaceutical companies that are set to take the stage. These companies are not just participants; they are leaders in transforming clinical trials through mobile health technology, making research more efficient and patient-centric. Stay tuned for updates and learn more: https://lnkd.in/ggv8w76s #MobileClin2024 #MobileInClinicalTrials #PharmaInnovation #ClinicalResearch #HealthcareTechnology #PharmaLeaders #DigitalHealth #MobileHealth

It is my best opportunity to share my acquaintance with everyone here that I was delighted to attend the FIP digital event by the International pharmaceutical Federation. The theme was "The patient Voice in Generic Medicine Development" which was conducted on 15th November 2022. The objective of the event was: 1. The FDA's perspective on a patient's role in Drug Development. 2. How the Office of Generic (OGD) Drug is working on Patients engagement. # FDA has a wise perspective on a patient's role in drug development. They have organized : * FDA patient representative program * FDA patient listening session * CDER patient focused drug development * Patient Engagement Collaborative OGD patient focused initiatives: 1. OGD focuses on patient accessibility and affordability of medication. 2. Prioritizing beyond the first generic helps drive down the cost of treatment. 3. Prioritizing the assessment of other key drug products such as those in shortage or supporting a public health emergency.

80% of the global population in low- and middle-income countries (#LMICs) faces significant barriers in accessing essential healthcare products - but access alone is not enough. The real challenge lies in ensuring those medicines reach patients who need them most. After all, expanding access has little meaning if it doesn’t create real impact for underserved communities. Discover more tomorrow with the launch of our 2024 Access to Medicine Index #ATMI24.

COMING SOON: The 2024 Access to Medicine Index #ATMI24 will shine a spotlight on how 20 of the world’s largest #pharma companies are stepping up – or falling short – in ensuring their essential medicines reach underserved populations. A major highlight of this ninth iteration of the Index is its focus on the critical issue of how pharmaceutical companies are reaching patients worldwide, especially in low- and middle-income countries #LMICs. Our latest report builds on data from the 2024 Access to Medicine Index and examines current approaches to measure and report #PatientReach, mapping the existing landscape and highlighting interventions that are critical to ensure more patients benefit from increased #AccesstoMedicine. Read the report on patient reach ➡ https://lnkd.in/e8TxU4mV #EquitableAccess #AccesstoHealthcare #HealthEquity #GlobalHealth

In your healthcare journey, how confident are you in the quality of #medicines you are using? Who do you believe has the competencies and responsibility to ensure you get the right medicines every time? What would it mean for you if you knew you could contribute to guaranteeing the quality of #HealthProducts you are using? Join us for the #EndYearDinner to listen in, engage with and shape the future as we chart a path forward in tackling the burden of substandard and falsified medicines in #Africa. Fight the Fakes Alliance UCL Fight the Fakes Medicines for Malaria Venture medicines for africa (mfa) Access to Medicine Foundation Access Accelerated Market Access Africa GS1 Kenya Association of Pharmaceutical Industry (KAPI) Kenya Healthcare Federation (KHF) Kenya Medical Association Pharmaceutical Society of Kenya